Can a smart inhaler deliver better asthma care for kids?

NCT ID NCT06290102

Completed Disease control Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial is testing a new inhaler that combines two asthma medications—fluticasone propionate and albuterol sulfate—in a single device with an electronic module. The study involves children aged 4 to 11 with stable asthma. The goal is to measure how much of the medication gets into the body and to compare it with an existing inhaler. The study also checks for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fluticasone propionate and albuterol sulfate combination inhaler
What this could lead to: If successful, this could lead to a more convenient and effective inhaler for children with asthma, potentially improving symptom control.
What could go wrong: This is an early-stage trial with a small number of participants, so results may not apply to all children. The study focuses on drug levels and safety, not long-term effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Teva Investigational Site 12001

Boerne, Texas, 78006, United States
Teva Investigational Site 12002

Miami, Florida, 33155, United States
Teva Investigational Site 12003

Long Beach, California, 90815, United States
Teva Investigational Site 12005

Miami, Florida, 33142, United States
Teva Investigational Site 12007

Miami, Florida, 33130, United States
Teva Investigational Site 12008

Lafayette, Louisiana, 70508, United States
Teva Investigational Site 12009

San Antonio, Texas, 78249, United States
Teva Investigational Site 12010

Mobile, Alabama, 36608, United States
Teva Investigational Site 12011

Columbia, Missouri, 65203, United States
Teva Investigational Site 12012

Oklahoma City, Oklahoma, 73120-9389, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.